| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | M-1 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
| Reversed phase POSITIVE ION MODE | M-3 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
| Reversed phase POSITIVE ION MODE | M-4 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
| Reversed phase POSITIVE ION MODE | M-5 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
| Reversed phase POSITIVE ION MODE | M-6 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
| Reversed phase POSITIVE ION MODE | M-7 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
| Reversed phase POSITIVE ION MODE | G-1 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
| Reversed phase POSITIVE ION MODE | G-2 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
| Reversed phase POSITIVE ION MODE | G-4 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
| Reversed phase POSITIVE ION MODE | G-5 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
| Reversed phase POSITIVE ION MODE | G-6 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
| Reversed phase POSITIVE ION MODE | G-7 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
| Reversed phase NEGATIVE ION MODE | M-1 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
| Reversed phase NEGATIVE ION MODE | M-3 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
| Reversed phase NEGATIVE ION MODE | M-4 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
| Reversed phase NEGATIVE ION MODE | M-5 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
| Reversed phase NEGATIVE ION MODE | M-6 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
| Reversed phase NEGATIVE ION MODE | M-7 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
| Reversed phase NEGATIVE ION MODE | G-1 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
| Reversed phase NEGATIVE ION MODE | G-2 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
| Reversed phase NEGATIVE ION MODE | G-4 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
| Reversed phase NEGATIVE ION MODE | G-5 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
| Reversed phase NEGATIVE ION MODE | G-6 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
| Reversed phase NEGATIVE ION MODE | G-7 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
Return to study ST002121 main page
Download data matrix(Functional metabolic molecule were identified as novel therapeutic targets to facilitate gemcitabine treatment against pancreatic cancer (Tumor tissues metabolomics) Reversed phase POSITIVE ION MODE)
Download data matrix(Functional metabolic molecule were identified as novel therapeutic targets to facilitate gemcitabine treatment against pancreatic cancer (Tumor tissues metabolomics) Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|